
The following is a conversation with Prof Vincent Rajkumar is engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. Dr. Rajkumar served as the principal investigator on several clinical trials for the treatment of myeloma. We talk with him about myeloma, COVID, how he thinks trainees can make sense of all the data out there, access to treatments and drug costs.
Interview: Nico Gagelmann, Claire Horgan